Teaching machines, empowering scientists.
We are a new generation of biotech company with an AI-first approach. By unlocking previously inaccessible insights into protein biology, we empower scientists and dramatically accelerate the entire early drug discovery process. Our powerful technology not only advances our internal pipeline of promising targets but also fortifies the pharmaceutical industry addressing some of the world's most pressing health challenges.
Our technology
We have started to develop our AI technology in early 2021 in collaboration with Helmholtz Munich. Our AI has learned and continues to learn from the vast amount of knowledge in biochemistry to unveil interactions and relations between proteins and small molecules that are too complex to grasp for humans. This enables researchers to streamline their drug development efforts and base their experimental decisions on a clear understanding of the underlying biology. The effectiveness and power of this technology has been demonstrated in the most recent public benchmarks as well as in wet laboratory studies.
Docking is one of the multiple applications of our AI system. We have achieved best-in-class results on the recent Posebuster benchmark and drastically outperformed any of the classical docking methods. As our docking approach is built on top of the data generated by our AI this showcases the power of our fundamental technology which extends far beyond docking. It excels in particular in every med chem journey as it gives medicinal chemists precise insights and guidance on how to optimize molecules along the way. This reduces costs dramatically while achieving better results at the same time.
© 2024 khumbu.ai GmbH